Diamant, M., Van Gaal, L., Stranks, S., Guerci, B., MacConell, L., Haber, H., . . . Trautmann, M. (2012). Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks. American Diabetes Association.
Chicago Style citaatDiamant, Michaela, Luc Van Gaal, Stephen Stranks, Bruno Guerci, Leigh MacConell, Harry Haber, Jamie Scism-Bacon, en Michael Trautmann. Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks. American Diabetes Association, 2012.
MLA citatieDiamant, Michaela, et al. Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks. American Diabetes Association, 2012.